The University of Minnesota finalises second license with startup International Cardio for ultrasound technology to tackle artery disease.

The University of Minnesota has finalised a second license with International Cardio Corporation (ICC) for an ultrasound-based technology which could benefit millions with artery disease. It follows a license in 2011 between the two for technologies which treat plaque build-up in the artery walls. The build-up leads to peripheral artery disease, a condition that affects…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.